Seres Therapeutics Inc Cash Flow Quality Index
Seres Therapeutics Inc cash flow quality index. Seres Therapeutics Inc (MCRB) has a Cash Flow Quality Index of -4.89x as of June 2026. Operating cash flow of $-22.39 Million is below net income of $4.58 Million, suggesting accrual-heavy earnings not yet converted to cash. See Seres Therapeutics Inc (MCRB) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Seres Therapeutics Inc (2024–2025)
Cash flow quality index of Seres Therapeutics Inc from 2024 to 2025. Historical Cash Flow Quality Index for Seres Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore MCRB operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Seres Therapeutics Inc Cash Flow Quality Index by Year (2024–2025)
Seres Therapeutics Inc cash flow quality index by year from 2024 to 2025. Year-by-year earnings quality comparison for Seres Therapeutics Inc. For the full cash flow conversion analysis, see MCRB cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $1.12 Million | $5.70 Million | ▲ +100.0% |
| 2024 | -1092.71x | $-148.61 Million | $136.00K | — |